Literature DB >> 10340895

Does size matter? Association between number of patients treated and patient outcome in metastatic testicular cancer.

E J Feuer, J Sheinfeld, G J Bosl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10340895     DOI： 10.1093/jnci/91.10.816

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  7 in total

Review 1.  Secondary surgery in germ cell tumors--when and how extensively should it be performed?

Authors:  Richard S Foster; Stephen Beck; Richard Bihrle
Journal:  World J Urol       Date:  2004-03-30       Impact factor: 4.226

2.  Ten thousand attentive hours, rapid learning, dissemination of knowledge and the future of experience-based care in germ-cell tumors.

Authors:  C Nichols; T Tandstad; W Lowrance; S Daneshmand
Journal:  Ann Oncol       Date:  2018-02-01       Impact factor: 32.976

3.  Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm.

Authors:  Torgrim Tandstad; Christian K Kollmannsberger; Bruce J Roth; Claudio Jeldres; Silke Gillessen; Karim Fizazi; Siamak Daneshmand; William T Lowrance; Nasser H Hanna; Costantine Albany; Richard Foster; Gabriella Cohn Cedermark; Darren R Feldman; Thomas Powles; Mark A Lewis; Peter Scott Grimison; Douglas Bank; Christopher Porter; Peter Albers; Maria De Santis; Sandy Srinivas; George J Bosl; Craig R Nichols
Journal:  J Clin Oncol       Date:  2017-08-30       Impact factor: 44.544

4.  Application of the International Germ Cell Consensus Classification to the Nova Scotia population of patients with germ cell tumours.

Authors:  Elana Maydanski Murphy; Jo-Anne Douglas; Kara Thompson; Lori Wood
Journal:  Can Urol Assoc J       Date:  2009-04       Impact factor: 1.862

Review 5.  [Stage-specific treatment for testicular germ cell tumours].

Authors:  A Heidenreich; C Bokemeyer; R Souchon
Journal:  Urologe A       Date:  2009-04       Impact factor: 0.639

6.  Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.

Authors:  Samuel A Funt; Deaglan J McHugh; Stephanie Tsai; Andrea Knezevic; Devon O'Donnell; Sujata Patil; Deborah Silber; Maria Bromberg; Maryann Carousso; Victor E Reuter; Brett S Carver; Joel Sheinfeld; Robert J Motzer; Dean F Bajorin; George J Bosl; Darren R Feldman
Journal:  Oncologist       Date:  2021-03-12

7.  Identical chemotherapy schedules given on and off trial protocol in small cell lung cancer: response and survival results.

Authors:  J A Burgers; A Arance; L Ashcroft; J Hodgetts; L Lomax; N Thatcher
Journal:  Br J Cancer       Date:  2002-08-27       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.